Rheumatoid arthritis (RA) is the commonest chronic, systemic, inflammatory disorder affecting ∼1% of the world population. It has a strong genetic component and a growing number of associated genes have been discovered in genome-wide association studies (GWAS), which nevertheless only account for 23% of the total genetic risk. We aimed to identify additional susceptibility loci through the analysis of GWAS in the context of biological function. We bridge the gap between pathway and gene-oriented analyses of GWAS, by introducing a pathway-driven gene stability-selection methodology that identifies potential causal genes in the top-associated disease pathways that may be driving the pathway association signals. We analysed the WTCCC and the NARAC studies of ∼5000 and ∼2000 subjects, respectively. We examined 700 pathways comprising ∼8000 genes. Ranking pathways by significance revealed that the NARAC top-ranked ∼6% laid within the top 10% of WTCCC. Gene selection on those pathways identified 58 genes in WTCCC and 61 in NARAC; 21 of those were common (P overlap < 10 221 ), of which 16 were novel discoveries. Among the identified genes, we validated 10 known RA associations in WTCCC and 13 in NARAC, not discovered using single-SNP approaches on the same data. Gene ontology functional enrichment analysis on the identified genes showed significant over-representation of signalling activity (P < 10 229 ) in both studies. Our findings suggest a novel model of RA genetic predisposition, which involves cell-membrane receptors and genes in second messenger signalling systems, in addition to genes that regulate immune responses, which have been the focus of interest previously.
INTRODUCTION
Rheumatoid arthritis (RA) is the commonest inflammatory joint disease affecting over 1% of Caucasian populations. The disorder results in chronic inflammation of multiple peripheral joints leading to destruction of cartilage and bones, progressive deformity and severe disability. The aetiology and pathogenesis of RA remains unknown (1, 2) , but immunological factors clearly play a major role which is supported by the presence of inflammatory cells in the synovium, the association of the disease with autoantibodies, the cellular infiltration in inflamed tissues and the response of patients to immunomodulatory therapy (3) . However, a number of clinical features suggest involvement of non-immune mechanisms: the progressive increase of RA incidence over the age of 50, the presence of subcutaneous nodules of proliferating cells at pressure points, the association of disease with osteopenia and proliferative and destructive lesions in cartilage, bones and other organs (1, 2) .
Over the past decade, research has focused on identifying the genetic basis of RA as a means to understand the biology of the disease. A growing number of genes have been associated with RA in recent genome-wide association studies (GWAS) (4 -6) . However, the 31 loci confirmed to date (6) , including the well-established associations of the HLA genes of the major histocompatibility complex (MHC), explain only 23% of the genetic risk to RA (7) , and their functional implication to disease pathogenesis is yet to be fully explained.
There is much debate about the source of this 'missing heritability' (8) , but one possibility is that RA, as any other common complex disease, arises on the basis of the cumulative effect of many variants yet to be discovered, because they are either rare (with potentially large effect) or have a small effect (but are potentially common). Such variants are challenging to identify when performing standard single-SNP analyses of GWAS data. Increasing the sample size via meta-analysis has been an effective way of detecting additional variants; however, this strategy is ultimately limited by the number of genotyped cases in each study.
We have previously hypothesized that multiple variants within a gene or a biological pathway may act additively to determine disease susceptibility, and have reported that we could detect this cumulative effect by analysing GWAS at the level of multiple SNPs within biological pathways (9) . Indeed, various methods have been proposed to perform such joint analysis using combination statistics (10) , an adaptive rank-truncated product (11) , a multivariate score test (Hotelling's test) (12), Fisher's method for combining P-values and the minimum P-value approach (13), a Fourier-transform-based approach (14) , genetic similarity matrices (15) and principal component analysis (16, 17) . Genecentric approaches (18) (19) (20) summarize the genetic variation of a gene, but they do not model the effect of multiple functionally interacting genes, which results in limited power (9, 21) . Pathway-driven approaches (6, (22) (23) (24) are more powerful, as they take into account the biological interplay of genes and they are attractive in that they provide insight into how multiple genes might contribute to disease biology. Nevertheless, the vast majority of these pathway methods do not account for the overlap of genes in multiple pathways, as where there are causal genes lying in multiple pathways these pathways will show somewhat misleading association (25) . Moreover, these approaches do not identify the causal genes within pathways (6,22-24,26 -28) , which limits their biological interpretability.
In this report, we go beyond a simple pathway-based analysis of GWAS to identify the genes within associated pathways that are predominantly responsible for the pathway association signal. To achieve this, we recast the question of how to associate genes with a disease as a pathway-driven stabilityselection problem. Stability selection is a technique that is based on sub-sampling (of individuals) in combination with variable selection algorithms (29) . Variable selection methods attempt to identify combinations of variables (in this case SNPs) that best explain the outcome (disease status). Regularization parameters control the number of variables selected: smaller models (stronger regularization) result in a lower false discovery rate (FDR) but may miss real-associated variables; larger models (weaker regularization) detect more real-associated variables but also admit more false positives. Stability selection (29) involves variable selection on multiple random sub-samples of the data (in this case individuals), and across multiple regularization parameter settings (29) . Variables which are consistently chosen are reported as 'stably selected'.
RESULTS
We applied our approach on two RA case-control GWAS; the Wellcome Trust Case Control Consortium (WTCCC) RA study, of 1860 cases and 2938 controls typed on the Affymetrix 500 K chip (4) and the North American Rheumatoid Arthritis Consortium (NARAC) study of 908 cases and 1260 controls genotyped on the Illumina Humanhap550 (5). A diagram of our suggested strategy is given in Figure 1 .
To identify the biological pathways with the genes responsible for RA susceptibility, we examined 700 curated pathways, as assembled from KEGG, BioCarta and GenMAPP. We used our previously reported cumulative trend (CT) test statistic (9) to examine the association between RA and the cumulative genetic variation of each biological pathway. We calculated the x 2 1 -scores from the CT P-values (Supplementary Material, Fig. S1 ) and found that the correlation between the two studies was highly significant (Spearman's r 2 ¼ 0.69, P , 2.2 × 10
216
). This correlation persisted even after removal of pathways that included strong and confirmed associated loci with RA, such as the HLA genes within the MHC region (Spearman's r 2 ¼ 0.32, P , 2.2 × 10 216 ). Pairwise correlation of pathway statistics between studies (which were carried out in independent populations and on different genotyping platforms) should indicate common genetic variation associated with RA. Ranking of the pathways revealed a 95% overlap in the top-ranked pathways between the two studies at a 2% rank cut-off (14 pathways), comprising pathways which are dominated by the known MHC RA associations; at the same time a 70% overlap was observed at a 6% cut-off (42 pathways, Supplementary Material, Fig. S2a ). To help choose a threshold for which significant pathways to take forward, we plotted the maximum rank in one study as a function of the rank threshold in the other study (Supplementary Material, Fig. S2b and c) and we observed that the maximum WTCCC rank undergoes a step change from 10 to 50% at this 6% threshold. Conversely, the maximum NARAC rank makes a similar transition at a lower 2% threshold, indicating that the WTCCC pathway ranks may be less reliably reproducible in NARAC. We thus decided that taking forward the NARAC top-ranked 6%, comprising 42 pathways, provided a good balance between introducing noise and increasing the computational demands of the variable selection step, and potentially missing genuineassociation signals. The 42 associated pathways with the CT P-values and their ranks in both studies are listed in Table 1 and the database from which each pathway came is shown in Supplementary Material, Table S8 .
A gene composition similarity matrix, as shown in Supplementary Material, Figure S3 , revealed that many of the significant pathways share the same genes. We therefore Human Molecular Genetics, 2011, Vol. 20, No. 17 3495 speculated that there is an underlying group of genes acting in the associated pathways, which may be driving this correlation in pathway significance. We selected the 2156 genes comprising the 42 pathways significant in both studies to carry forward to our gene stability selection. Stability selection was carried out using the HyperLasso algorithm which implements variable selection in logistic regression (21) . The penalty parameter f ′ of the HyperLasso controls the size of the fitted models. We defined a grid of penalty values f ′ xL and for each value of f ′ xL we generated 1000 random sub-samples each consisting of 50% of the individuals, sampled without replacement, and generated a set of selected SNPs for each sub-sample using HyperLasso (21) . We then calculated selection probabilities for each gene by mapping the selected SNPs to their corresponding genes. In order to avoid spuriously selecting large genes, we split genes into LD based geneblocks. All subsequent analysis is carried out at the level of gene blocks. The selection probability p(g|f ′ ) of a gene-block g at a value of f ′ was defined as the fraction of sub-samples in which at least one SNP of the gene-block g was selected. The stability path of a gene-block g was defined as the line that fits the selection probability over the range of all penalty values f ′ xL. Full description of the steps are provided in Materials and Methods. We broadly observed that stability paths with consistently high p(g|f ′ ) across f ′ xL correspond to the major hits found in single SNP analyses in each study; for instance TRAF1/ C5, HLA-DRB1 and MICA in NARAC; IL2RA, PTPN22, HLA-DRA and MICA in WTCCC. At the other extreme, we expect that stability paths with low p(g|f ′ ) across f ′ xL comprise non-associated gene-blocks. In between these two extremes lie many stability paths that have low selection probability under strong regularization and high selection probability under weak regularization.
In order to extract from this class the 'stably selected' variables, Meinshausen and Buhlman (29) suggest choosing a threshold p thr , such that 0 , p thr , 1 and retaining everything with p(g|f ′ ) . p thr , for some small f ′ xL. However, this focuses only on a single point of the stability path. We propose instead to weight the selection probabilities along all points of the path according to a prior belief p(f ′ ) as to the reliability of inferences made at each f ′ xL and then retain all genes with weighted sum
. p thr. The WTCCC study had greater power as it was more than twice the size of NARAC, and so generated substantially larger models for the same value The cumulative trend (CT) statistic P-values are adjusted at a ¼ 0.05 with the Benjamini-Hochberg method that controls the FDR. Number of SNPs per pathway might differ between studies, because they refer to the typed markers. The pathways appear in the order of ascending NARAC ranks.
of f ′ . In order to equalize the power between these two data sets, we derived study-specific prior weights so as to equalize the expected model size (E[size]), such that in the smaller study more weight is given to the models fitted under looser values of f ′ and vice-versa. (Full description of the methodology is provided in Materials and Methods).
We calculated the number of selected gene-blocks which overlap between the two studies as well as the median FDR and 95% confidence interval (CI) among these common genes ( Fig. 2A ). In addition, we sought to maximize the number of observed common gene-blocks between studies, while controlling the FDR ( Fig. 2A) . We conducted sensitivity analysis around E[size], controlled by the prior distribution p(f ′ ), and p thr (fully described in Materials and Methods). A good trade-off was observed at E[size] ¼ 400 and p thr ¼ 0.4, for which we selected 58 genes in WTCCC and 61 genes in NARAC (that is 60 gene-blocks in WTCCC and 64 geneblocks in NARAC), of which 21 are common (P ¼ 10 220 ) and the median FDR is 5% with 95% CI of [0 -19%] as shown in Figure 2B . The selected gene-blocks in WTCCC and NARAC are shown in Supplementary Material, Tables S1 and S2, respectively. In order to investigate the possible bias in favour of selecting gene-blocks which have a greater number of typed SNPs, we compared the distributions of number of typed SNPs (#SNPs) per gene-block among selected gene-blocks and non-selected gene-blocks (however, still within pathways carried forward to variable selection) (Supplementary Material, Fig. S4 ). There is an overrepresentation of selected gene-blocks in the region 20 ,#SNPs ,70 (which shows a tendency to select larger gene-blocks) and otherwise an under-representation. To ensure that this bias does not invalidate our overlap statistics, we recalculated an overlap significance of P , 10 24 based on sampling 10 000 times from the null distribution of number of common gene blocks under the assumption of nonrandom selection of gene-blocks according to #SNPs (see Materials and Methods).
For the majority of genes, only one gene-block was selected, but for ADCY2 and FHIT in WTCCC and FHIT and PTPRN2 in NARAC, two/three LD blocks exhibited stable selection. We considered a gene found in one study to replicate in the other study, only if the same gene-block was selected in both. Known associations comprise 10 of 58 in WTCCC; 13 of 61 in NARAC and 5 of 21 common genes. Of the 58 and 61 genes selected independently in NARAC and WTCCC from an original pool of 2156 genes, more than 50% were either common between studies or previous RA associations and hence can be considered as validated. The stability paths of the selected gene-blocks in each study are shown in Figure 1C and D; the subset of stability paths The number of selected genes per study (n WTCCC , n NARAC ) is shown above the curves followed by the number of genes in common (r) and the hypergeometric probability of the observed overlap by chance. The median FDR and the 95% CI around it are given below the curve. The asterisk shows that for p thr ¼ 0.4, we achieve the maximum number of genes that overlap with a median FDR ¼ 5% [0,19%] . (C and D) Stability paths of the 60 and 64 gene-blocks selected in WTCCC (C) and NARAC (D), respectively. Gene names are shown in the legend followed by a number that indicates the selected gene-block.
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for previously known associations is shown in Supplementary Material, Figure S5a and b and the stability paths of geneblocks that were not selected are shown in Supplementary Material, Figure S5c and d. We then investigated whether common genes were driving the association signals of multiple pathways by mapping the selected genes back to their original pathways ( Table 2 ). The striking majority of selected genes, to name a few: the HLA genes, ADCY2, ADCY8, CACNA1A, DGKH, FLNB, ITGA1, PRKCA, PRKCQ, SHC4, VAV3 were indeed involved in more than one of the 42 pathways. On the other hand, some selected genes such as IRF5, MAPKAPK2, PDE10A, PDE1C, PSMD13 and TEC were only involved in one pathway ( Table 2 ). We observed that the very top-ranked pathways were mostly driven by the HLA genes and six pathways were driven entirely by known associations, the HLA-DRA, HLA-DRB1 and CD28 genes in particular. The majority of pathway signals (18 pathways) were driven by a combination of previously reported associations as well as novel associations. A further 14 pathways were driven only by our newly reported associations and surprisingly four pathways had no gene selected.
Finally, we calculated the inverse variance weighted meta-analysis P-value for the SNP selected most frequently in each study in the 21 commonly selected genes using PLINK (30) . The meta-analysis P-value was ,0.05 for all SNPs (Table 3) .
In order to characterize the functional role of the identified genes, we assigned the identified genes to their cellular location using Ingenuity Pathways Analysis (Fig. 3 ). There was a significant over-representation of genes located in the cell membrane (compared with the location of all annotated human genes), all of which are involved in signalling from the cell exterior to the interior. We then performed a gene ontology (GO) functional enrichment analysis using GOrilla (31) and we finally created a schematic map (Fig. 4 ) of how these genes might act together in biological processes to determine RA susceptibility.
In addition to the expected involvement of HLA-mediated processes (GO:0032395, P ¼ 5. ), which contain genes involved in intracellular signalling through second messenger systems (SMSs) (32, 33) . The SMSs are conserved, ubiquitous systems that relay signals from cell-surface receptors to target molecules in the cytosol or nucleus, and greatly amplify the strength of the signal, through release of the second messengers: cyclic adenosine monophosphate (cAMP); inositol triphosphate (ITP)/ diacylglycerol (DAG) and calcium ions (Ca 2+ ) (32) (33) (34) . Adenylate cyclase genes (ADCY2, ADCY8, ADCY9) synthesize cAMP that activates multiple protein kinases (Fig. 4) . The activity of cAMP is then terminated by the phosphodiesterase (PDE) enzymes, of which several genes (PDE10A, PDE4B, PDE4D) were identified in either WTCCC or NARAC data sets suggesting control of cAMP (GO:0004016, P ¼ 4.7 × 10 25 , GO:0004114, P ¼ 9.05 × 10
26
) as a potential key regulation point in RA pathophysiology.
The ITP/DAG system is activated by phospholipase C (PLC), which hydrolyses membrane phospholipids releasing DAG (Fig. 4) . DAG recruits calcium-dependent kinases that activate numerous pathways (GO:0045859, P ¼ 6.98 × 10
29
) including RAS, ERK and NFkB signalling, interacting with the p38, NFAT and STAT signalling pathways (32) . The actions of DAG are terminated by the enzyme diacylglycerol kinase (DGK). Protein kinase C (PRKC) requires calcium ions generated from the action of PLC on the complex of inositol 1,4,5-trisphosphate (ITP) and DAG. PLC releases ITP which diffuses through the cytosol and binds to ITP receptors (ITPR) on the endoplasmic reticulum causing the release of Ca 2+ into the cytosol (GO:0042325, P ¼ 2.99 × 10
210
). The identification of several genes in this system (DGKH, DGKI, PLCG2, PRKCA, PRKCQ, ITPR3) suggest the ITP/DAG signalling is another key regulatory step in RA (GO:00045859, P ¼ 6.98 × 10
29
). A further enriched SMS was the calcium SMS, which is based on cytosolic Ca 2+ triggering numerous cellular processes (34, 35) . (GO:0005262, P ¼ 1.64 × 10
28
; GO:0005245, P ¼ 1.11 × 10
211
, genes CACNA1A, CACNA1D, CACNA1E, CACNA2D1, CACNA2D3, CACNB2, CACNG5, ITPR3, VAV3). In addition to the release of Ca 2+ from the endoplasmic reticulum, the entrance of Ca 2+ into the cytosol from the exterior is also controlled by voltage-gated channels, receptoroperated channels (GO:007166, P ¼ 7.08 × 10
223
) and G-protein-coupled receptors, with an increase in cytosolic Ca 2+ activating numerous calcium-dependent proteins including PRKC (Fig. 4) .
Activation of protein kinase activity (GO:0032147, P ¼ 2.7 × 10
27
) and activation of phosphorylation (GO:0042325, P ¼ 2.99 × 10 210 ; GO:0001932, P ¼ 8.47 × 10
210
) were also enriched functional categories. The multiple identified genes coding for kinases and phosphatases (PRKCA, PRKCQ, PIK3R3, PPP3CA, PTPN22, PTPN5, MAPKAPK2, MAP3K4) are activated by the SMSs (Fig. 4) and regulate multiple cellular functions including cell turnover, metabolism, secretion and growth (33, 36, 37) .
Many of the remaining genes identified in either study that are not directly involved in receptor-mediated signalling or SMSs are also known to regulate these systems (Fig. 4) . The proteins encoded by VAV3, ALCAM, CD59, ITGB3 interact with those of EGFR, which interacts with GRB2, leading to RAS signal transduction. EGFR encoded protein also interacts with the SPRY1 protein which inhibits growth factor signalling. FGF5 and FGF6 are ligands for FGFR2 which interacts with GRB2. In terms of cytokines and their receptors, the encoded proteins of TNFAIP3, IRF5, SOCS1, SOCS6, STAT4 and PIAS2 are well-known downstream regulators of cytokine-induced inflammation, as are the encoded proteins of RAPGEF4, RAPGEF5, RASGRF2, PRKCQ and NFATC4. The biological interactions of all significant genes in both NARAC and WTCCC studies are shown schematically in Figure 4 as a functional cellular map. The GO enrichment functional analysis, cell-location mapping and the cellular map we created demonstrate further concordance between the findings in the two studies at the functional level. Other than the 21 genes that were identified in both WTCCC and NARAC studies, many of the genes, which were only selected in one study, had functional roles similar to genes selected in the other study.
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DISCUSSION
We have shown that using both biologically driven pathway information and a robust gene stability-selection methodology yields improved power and consistent results across two independent RA cohorts. We have shown that this approach can identify novel, reproducible associations from GWAS as well as replicate known associations that were not validated using single-SNP approaches using the same GWAS data. For example, the original NARAC report (5) , presented the TRAF1-C5 association and confirmed only the MHC region and the PTPN22 gene, whereas our approach on NARAC validated the CD247, CD28, CD40, IL2RB, PRKCQ, SPRED2 and TAP2 genes, which have been previously reported as modest associations with disease (6) . Similarly, in comparison to the original WTCCC report (4) that only confirmed the association of the MHC region and the PTPN22 gene, we also validated the associations of STAT4, TNFAIP3, IL2RA, IL2RB, IRF5 and IL6R (6). Furthermore, of the seven novel loci discovered in the recent meta-analysis of RA GWAS on a total of 41 282 samples (6), we discovered three (IL2RA, IRF5, SPRED2), and of the 10 suggestive loci, we discovered two (CD247, IL6R) using only two studies with 4798 (WTCCC) and 2168 (NARAC) samples each.
Our approach would also be applicable if only one GWAS cohort was available, although the calibration of the selection probability p thr and expected model size to maximize the number of discoveries and minimize the FDR would not be possible, and we would suggest using the values derived in Table 2 . Continued
Pathway
Number of SG / Number of PG
Selected genes
Glycan structures biosynthesis 1 0/117 -Pathways are in the same order as they appear in Table 1 . Column 2 shows the number of selected genes (SG) over the number of pathway genes (PG). Previously reported RA associations are underlined. Genes that appear in only 1 of the 42 pathways are followed by an asterisk ( * ). Genes without an asterisk act in more than 1 of the 42 pathways. Pairs of genes in italics indicate genes that overlap the same selected gene-block, but are in different pathways. The first listed gene in each pair is from the pathway indicated, while the second listed has a higher selection probability and hence is reported in our final list. HLA-DRA, HLA-DQA1, PTPN22, IL2RB and MICA have shown association in previous studies. The remaining 16 are novel associations cross-validating in both cohorts. The ORs were calculated with respect to the reported allele. The genes appear in the ascending order of their meta-analysis P-value.
a Original analysis on NARAC study identified rs2476601 (single SNP P ¼ 2 × 10 211 ) as the most significant SNP mapped to PTPN22 gene. We did not replicate this result as this SNP lies 68 kb away from the PTPN22 boundaries and we only mapped SNPs to genes within 20 kb of each side of the gene.
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this paper. If more than two GWAS cohorts were available, it would be straightforward to extend our approach using a multivariate hypergeometric distribution to assess the FDR. Our results suggest that our pathway-based and gene stability-selection analysis is robust to genetic heterogeneity between different samples and to the technical heterogeneity of different genotyping platforms. We have replicated our findings at the pathway level by identifying the same pathways in both studies lying in the top 6% of the rankings in NARAC and at the top 10% in WTCCC; at the gene level by identifying 21 genes in common of the 58 and 61 selected in WTCCC and NARAC studies, respectively, and by validating 8 (WTCCC) and 12 (NARAC) known associations that were not validated using single-SNP approaches on the same GWAS data; at the functional level through demonstrating that many genes selected in only one study have functionally similar genes selected in the other study. A recent review (38) commented that, at present, there is no clear way to compare various pathway analysis methods against each other, but there is a need to replicate association results. To our knowledge, this is the first combined pathway and gene-based methodology that has replicated association findings in two real GWAS data sets.
Finally, our functional analysis of the identified genes suggests that the underlying concept of RA as a largely autoimmune and inflammatory disease should be broadened. Our findings suggest that defective second messenger signalling through cAMP, ITP, DAG and Ca 2+ may be at the heart of RA predisposition. The SMSs are used by all cells to switch Figure 3 . Cellular location of products of the selected genes. Genes in red were selected in both WTCCC and NARAC; in yellow are genes selected only in NARAC; in blue are genes selected only in WTCCC. Pink indicates that the same gene was identified in both studies but a different gene-block in each study. Genes coding for extracellular proteins are predominantly growth factors. Genes coding for intracellular proteins are predominantly involved with signal transduction. Lines connecting genes indicate direct interactions as defined from Ingenuity Pathways Analysis knowledge base.
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on and off multiple processes including cell cycle, differentiation, growth, secretion and immune response (33, 34) . SMSs regulate both the intensity and duration of cellular responses and the identification of multiple genetic variants in the SMSs suggests that RA may arise from a defect in the on/off switch controlling both the amplitude and duration of key cellular functions. The SMSs control not only immune response cells but chondrocytes, osteocytes, connective tissue and blood vessel cells, as well as processes such as osteoclast resorption, differentiation of chondrocyte and osteoblasts and repair and removal of senescent cells (39, 40) . Thus a defect in on/off signalling may explain the widespread cellular and connective tissue disorder in RA in addition to abnormal function of inflammatory cells.
It is of interest that numerous cellular studies have documented alterations in cAMP, inositol phosphate and calcium signalling in RA, including abnormalities in these pathways in inflammatory cells in the joints, in in vivo studies of osteocytes and chondrocytes (40) (41) (42) (43) , supporting our hypothesis. Future studies should explore the relationship between genes identified and functional cellular responses to test this hypothesis, particularly as all steps in the processes we have implicated may be amenable to pharmacological manipulation. Our identification of the SMSs as playing a key role in RA susceptibility suggests a novel concept of the genetic mechanisms of the disease which potentially opens new avenues for pharmacological intervention to prevent and treat the disorder. . Cellular and functional map of non-HLA genes identified by stability selection. Purple-selected in both WTCCC and NARAC; blue-selected in WTCCC only; red-selected in NARAC only. Focus is given on the second messenger signalling systems (SMSs). In the cyclic AMP system (cAMP), adenylate cyclase (ADCY) synthesizes cAMP from ATP. ADCY is activated by a range of receptors including G-protein coupled receptors. cAMP activates protein kinases (PKA) that phosphorylate target proteins. The enzymes phosphodiesterase (PDE) terminate the activity of cyclic AMP switching off the process. The inositol triphosphate/diacylglycerol (ITP/DAG) system is activated by phospholipase C (PLC), which hydrolyses membrane phospholipids releasing DAG and ITP. DAG recruits calcium-dependent protein kinase C and D (PKC, PKD). These activate numerous pathways including RAS and ERK leading to cell turnover, IKK and activation of NF K B signalling and interaction with p38 MAP kinase, NFAT and STAT signalling pathways. The actions of DAG are terminated by the enzyme diacylglycerol kinase, which converts DAG to phosphatidic acid. PKC requires calcium ions (Ca 2+ ) and these are made available by the action of ITP in the calcium-signalling pathway. ITP, released from the complex with DAG by PLC, diffuses through the cytosol and binds to inositol triphosphate receptors (ITPR) on the endoplasmic reticulum causing the release of Ca 2+ into the cytosol. The calcium second messenger system is activated by release of ITP, which binds to the ITPR on the reticuloendothelial system triggering release of Ca 2+ from the ER into the cytosol. Entrance of Ca 2+ into the cytosol is also controlled by voltage-gated channels, such as CACNAC, ITPR or receptor-operated channels and G-protein-coupled receptors. The rise in Ca 2+ concentrations in the cytosol, as a result of influx from the endoplasmic reticulum or extracellular fluids through calcium channels, activates numerous calcium-dependent proteins including PRKC. The actions of Ca 2+ are terminated by active transport of Ca 2+ out of the cytosol using calcium ATPases or sodium calcium exchanges.
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MATERIALS AND METHODS
The flowchart of our proposed methodology is given in Figure 1 .
Pathway-based analysis
The CT test statistic (9) assesses the null hypothesis that the pathway does not comprise any genes that are associated with the disease. In our original publication (9), the null distribution is obtained via fitting a skew normal distribution to 1000 CT statistics under permuted phenotype labels, using the 'sn' package in R. In this work, we observed that the 'sn' package does not allow calculation of the lower tail of the cumulative distribution in log space, which enforces a lower bound on the reported significance levels. To address this problem, we calculated P-values by fitting a gamma distribution. We used the Kolmogorov -Smirnof test statistic, as well as visual inspection of QQ plots to determine that the gamma distribution provides as good a fit as the skew-normal. Correction for multiple testing and dependence between pathways due to shared genes was performed via the method of Benjamini -Hochberg -Yekutieli, which controls the FDR under dependency. We set the FDR at a ¼ 0.05. This procedure was applied independently to WTCCC and NARAC.
Gene stability selection
We selected the 2156 genes comprising the 42 pathways significant in both studies to carry forward to gene-based stability selection. SNPs were assigned to genes in a physical distance of 20 kb for each side of the gene. It has been suggested (27, 44) that choosing 20 kb is not entirely arbitrary since a recent study of gene expression showed that the majority of eQTLs lie within 20 kb of genes (45) . Stability selection requires a variable selection algorithm with a regularization parameter which controls the number of variables selected. In the original implementation of stability selection, the Lasso variable selection was used (29) , these authors then showed that a 'randomized Lasso' algorithm gave better selection properties. We used the HyperLasso variable selection algorithm (21) , which has similar properties with the randomized Lasso [Phil Brown and Jim Griffin contribution to the discussion of Meinshausen and Puhlman (29) paper and the author response]. The HyperLasso has two parameters, shape l and penalty f ′ , the regularization parameter. We fixed the shape parameter at l ¼ 1 (data not shown). We defined a grid of penalty values f ′ xL,(0,45), in increments of 3. For each value of f ′ xL, we generated 1000 random sub-samples each consisting of 50% of the individuals, sampled without replacement; the case-control ration remained constant across random sub-samples and we generated a set of selected SNPs for each sub-sample using HyperLasso (21) . The upper and lower bounds were chosen to fit models of plausible size (between 1 and 2000 covariates).
We then calculated selection probabilities for each gene. In order to avoid spuriously selecting large genes, we first split genes into LD based gene-blocks on the basis of recombination rates estimated using LDHat (46) on HapMap Phase II data. We assigned every position with recombination rate . ¼ 15 cM/Mb as the border of an LD region (corresponding to LD-regions with average size 35 kb). The selection probability of a gene-block p(g|f ′ ) is defined as the fraction of sub-samples in which at least one SNP in a gene-block g was selected. The stability path of a gene-block is defined as the selection probability over the range of all penalty values f ′ xL. We assume a gamma prior probability for the penalty with shape parameter k and scale parameter u,
with support truncated to lie within the lower and upper bound of the grid L. Therefore the expected probability of inclusion of a gene g, is given by the integral
which we approximate by
where D f ′ is the size of the intervals over which we approximate the continuous integrands by their values at f ′ . In order to define the parameters of the gamma prior, we notice that the model size can be approximated by an exponential function of f ′ (Supplementary Material, Fig. S6) , and fit the model
The expected posterior model size is given by
which leads to an expression for the shape parameter k in terms of the scale parameter u and the expected model size E[size]
Furthermore, we sought to equalize the spread of the posterior distribution of the model size by setting the scale parameter of the integrand in Eq. (5) to be the same in both studies, which Figure S7 . The total number of selected genes per study for various values of E[size] is shown in Supplementary Material, Figure S8 . We calculated the number of selected genes which overlap between the two studies, the median FDR and its 95% CI among these common genes ( Fig. 2A) . The FDR was defined as the fraction of overlapping genes which would have been expected to be selected by chance alone and was calculated using the hypergeometric distribution. We defined the FDR in terms of genes rather than geneblocks as we found this to be more conservative, due to the fact that the number of possible gene-blocks is much larger than the number of possible genes, whereas the two studies almost always selected the same gene-block within a common gene for p thr . 0.2.
Simulating overlap under non-random gene-block selection
Given the observed bias in the distribution of the number of typed SNPs (#SNPs) per selected gene block between selected and non-selected gene blocks, we recalculated the significance of the observed overlap assuming non-random gene block selection according to #SNPs. We first calculated the empirical probability of selecting a gene-block with n SNPs as p (n | selected) #(gene selected gene blocks with n SNPS). We then smoothed this probability distribution by setting p (n | selected) to be equal to its average in a moving 5-SNP window. We then calculated the probability of selecting each given gene-block g, with #SNPs ¼ #SNPs(g) as P(g|selected) =p(#SNPs(g)|selected)
* 1/#(geneblockswith#SNPs = #SNPs(g))
We can then sample two vectors of selected gene-blocks, of length N 1 and N 2 corresponding to the number of NARAC and WTCCC selected gene-blocks, and finally calculate the number of common gene-blocks selected.
Established RA associations
We considered as previously reported and established RA associations the genes that were listed in the two recent RA GWAS papers (5,47) a subsequent meta-analysis (6) and the Catalog of Published Genome-Wide Association Studies (http://www.genome.gov/26525384).
GO functional enrichment analysis
We conducted a GO enrichment analysis using GOrilla (31) on the genes that our gene-selection methodology identified. The selected genes were compared with all the typed genes on the chip of each study. We carried out this analysis on each study separately and we observed that the same functional categories were enriched. We repeated the analysis on the union of the identified genes. The GO enrichment P-values reported in the text correspond to the joint analysis; the GO P-values for each study separately are shown in Supplementary Material, Tables  S3 and S4 . We also carried out a sensitivity analysis on the effect of different p thr on the enriched GO categories. 
Web resources
The URLs for data presented herein are as follows: Kyoto Encyclopedia of Genes and Genomes (KEGG) Database (http://www.genome.jp/kegg/pathway.html), Biocarta (http:// www.biocarta.com/genes/index.asp), GenMAPP (http://www. genmapp.org/), Ingenuity Pathways Analysis (http://www. ingenuity.com/).
